EMILIN1 and gastric cancer: Modica et al. (2017) founded that EMILIN1 can silences the RAS-ERK pathway via alpha4beta1 integrin, decreasing tumor cell growth. Qi et al. (2019) confirmed that EMILIN1 regulates the expression of TSPAN9, creating an anti-tumor effect in gastric cancer.